February 8, 2016 / 4:42 PM / 2 years ago

BUZZ-Aurinia Pharmaceuticals Inc: Positive kidney drug study

** Canadian drug maker's U.S. listed shares up 22 pct at $2.67; shares rise as much as 51 pct to $3.30 earlier, their biggest percentage gain in more than 2 years

** Says its experimental drug, Voclosporin, reduced excessive protein in urine by 25 pct in patients with lupus nephritis at 8 weeks of treatment

** Condition of excessive protein in urine, or Proteinuria, indicates a significant risk of renal disease

** Voclosporin is being studied as a potential treatment for lupus nephritis, or an inflammation of the kidneys

** Up to Friday's close, stock had fallen 37 pct in the past 12 months

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below